<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_Washington_Parts skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:Washington/Parts</SPAN></H1><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><DIV id="menuContainer"><UL><LI><A href="https://2015.igem.org/Team:Washington">Home
                  </A></LI><LI><A href="https://2014.igem.org/Team:Washington">UW 2014</A></LI><LI><A href="https://2013.igem.org/Team:Washington">UW 2013</A></LI><LI><A href="https://2012.igem.org/Team:Washington">UW 2012</A></LI><LI><A href="https://2011.igem.org/Team:Washington">UW 2011</A></LI><LI><A href="https://2010.igem.org/Team:Washington">UW 2010</A></LI><LI><A href="https://2009.igem.org/Team:Washington">UW 2009</A></LI><LI><A href="https://2008.igem.org/Team:University_of_Washington">UW 2008</A></LI><LI><A href="https://2013.igem.org/Main_Page">iGEM Homepage</A></LI></UL><LI><A href="https://2015.igem.org/Team:Washington/Auxin">Auxin
 
                    </A></LI><LI><A href="https://2015.igem.org/Team:Washington/Auxin#Introduction">Introduction</A></LI><LI><A href="https://2015.igem.org/Team:Washington/Auxin#Methods">Methods</A></LI><LI><A href="https://2015.igem.org/Team:Washington/Auxin#Results">Results</A></LI><LI><A href="https://2015.igem.org/Team:Washington/Auxin#Conclusion">Conclusion</A></LI><LI><A href="https://2015.igem.org/Team:Washington/Auxin#Biobrick">Biobrick</A></LI></DIV><LI><A href="https://2015.igem.org/Team:Washington/Aptazyme">Aptazyme
                    </A></LI><LI><A href="https://2015.igem.org/Team:Washington/Aptazyme#Introduction">Introduction</A></LI><LI><A href="https://2015.igem.org/Team:Washington/Aptazyme#Methods">Methods</A></LI><LI><A href="https://2015.igem.org/Team:Washington/Aptazyme#Results">Results</A></LI><LI><A href="https://2015.igem.org/Team:Washington/Aptazyme#Conclusion">Conclusion</A></LI><LI><A href="https://2015.igem.org/Team:Washington/Aptazyme#Biobrick">Biobrick</A></LI><LI><A href="https://2015.igem.org/Team:Washington/Paper_Device">Paper Device               
                    </A></LI><LI><A href="https://2015.igem.org/Team:Washington/Paper_Device#Introduction">Introduction</A></LI><LI><A href="https://2015.igem.org/Team:Washington/Paper_Device#Methods">Methods</A></LI><LI><A href="https://2015.igem.org/Team:Washington/Design">Design</A></LI><LI><A href="https://2015.igem.org/Team:Washington/Paper_Device#Results">Results</A></LI><LI><A href="https://2015.igem.org/Team:Washington/Paper_Device#Conclusion">Conclusion</A></LI><LI><A href="https://2015.igem.org/Team:Washington/Modeling">Modeling               
                    </A></LI><LI><A href="https://2015.igem.org/Team:Washington/Modeling#Paper_Device">Paper Device</A></LI><LI><A href="https://2015.igem.org/Team:Washington/Modeling#Aptamer">Aptamer</A></LI><LI><A href="https://2015.igem.org/Team:Washington/Practices">Human Practices               
                    </A></LI><LI><A href="https://2015.igem.org/Team:Washington/Practices#Outreach">Outreach</A></LI><LI><A href="https://2015.igem.org/Team:Washington/Practices#Integrated">Integrated</A></LI><LI><A href="https://2015.igem.org/Team:Washington/Protocols">Protocols
                    </A></LI><LI><A href="https://2015.igem.org/Team:Washington/Protocols#Experiments">Experiments</A></LI><LI><A href="https://2015.igem.org/Team:Washington/Protocols#Safety">Safety</A></LI><LI><A href="https://2015.igem.org/Team:Washington/Team">Team                         
                    </A></LI><LI><A href="https://2015.igem.org/Team:Washington/Team#Members">Members</A></LI><LI><A href="https://2015.igem.org/Team:Washington/Team#Attributions">Attributions</A></LI><LI><A href="https://2015.igem.org/Team:Washington/Team#Sponsors">Sponsors</A></LI><LI><A href="https://2015.igem.org/Team:Washington/Team#Judging_Form">Judging Form</A></LI></DIV><DIV id="main"><DIV id="contentContainer"><H2><DIV id="Biobrick"> Biobricks </DIV></H2><H4>Parts in the registry</H4><CENTER><P>&lt;groupparts&gt;iGEM015 Washington&lt;/groupparts&gt;</P></CENTER><P>
We also have an automatically generated <A href="http://partsregistry.org/cgi/partsdb/pgroup.cgi?pgroup=iGEM2015&amp;group=Washington">Team Parts</A> page.

                    </P><H2>Auxin</H2><P align="justify"> This part, called AFB2, is an F-box protein that binds the common plant hormone auxin. F-box proteins contain an F-box domain that mediates degradation of other proteins by recognizing substrates for ubiquitination. </P><P align="justify"> In our system, a dCas9-degron-repressor complex represses expression of lacZ. In the presence of auxin, the F-box protein and the presence of auxin, the AFB2 binds to auxin and auxin also binds to a degron; the F-box protein then recruits the ubiquitin ligase to degrade the dCas9-degron-repressor complex. When this occurs, lacZ is no longer repressed and production of beta galactosidase occurs. Beta galactosidase acts as a reporter for the presence of auxin. </P><H2>Apatazyme</H2><H2>yeVenus-TheoA; Coding sequence for enhanced YFP and theophylline-sensative aptazyme</H2><CENTER><A href="http://parts.igem.org/Part:BBa_K1711001">BBa_K1711001</A></CENTER><P>The part contains the coding sequence for yeast enhanced yellow fluorescent protein (yeVenus), linked to it is a gene for a theophylline sensitive riboswitch aptazyme. The aptazyme portion of the transcript self-cleaves in the absence of theophylline and no YFP should be produced. The theophylline bound state stabilizes the transcript, which translates to the protein and fluorescence should be observed.</P><H2>yeVenus-PEST-TheoA; Coding sequence for destabilized YFP Venus and theophylline-sensitive aptazyme</H2><CENTER><A href="http://parts.igem.org/Part:BBa_K1711002">BBa_K1711002</A></CENTER><P>This part, yeVenus-PEST-TheoA, contains the coding sequence for a hybrid protein made of yeast enhanced yellow fluorescent protein (yeVenus) fused in frame with the CDS of the PEST-rich 178 c-terminal residues of Cln2, which targets the protein for ubiquitin dependent degradation. These coding sequences are fused with a gene for a theophylline sensitive riboswitch aptazyme. The aptazyme portion of the transcript self-cleaves in the absence of theophylline and no YFP should be produced. The theophylline bound state stabilizes the transcript, which translates to the protein and fluorescence should be observed.</P></DIV></DIV></DIV></DIV></DIV></BODY></HTML>